caffeine / choline

RxCUI
1436556
RxNorm name
caffeine / choline
Term type
MIN
Status
Active
Updated
2026-10-29 07:09:03

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102013
Active start
102013
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
choline2449

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcaffeine / choline1NAMES
RxNorm Namecaffeine / choline1NAMES
TTYMIN1ATTRIBUTES
RxCUI14365561CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN02BASalicylic acid and derivativesATC1-4choline salicylate
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD002794CholineCHEMhas_ingredientcholine
MEDRTD002794CholineCHEMhas_ingredientcholine salicylate
MEDRTD004338Drug CombinationsCHEMhas_ingredientcholine salicylate
MEDRTD012459SalicylatesCHEMhas_ingredientcholine salicylate
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treatcholine salicylate
MEDRTD002796Choline DeficiencyDISEASEmay_treatcholine
MEDRTD002796Choline DeficiencyDISEASEmay_preventcholine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withcholine salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withcholine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD007228Infant Nutrition DisordersDISEASEmay_preventcholine
MEDRTD010003OsteoarthritisDISEASEmay_treatcholine salicylate
MEDRTD010146PainDISEASEmay_treatcholine salicylate
MEDRTD011247PregnancyDISEASEci_withcholine salicylate
MEDRTD012213Rheumatic FeverDISEASEmay_treatcholine salicylate
MEDRTN0000000142Biological Macromolecular ActivityMOAhas_moacholine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moacholine salicylate
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008337Cellular Activity AlterationPEhas_pecholine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pecholine salicylate
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pecholine salicylate
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS